Tirzepatide is a synthetic peptide that functions as a dual receptor agonist targeting GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It has been studied for its effects on glucose-dependent insulin signaling, glucagon regulation, metabolic signaling, and energy balance.
Structure: 39-amino-acid synthetic peptide conjugated to a C20 fatty diacid moiety
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈ (free-base form)
Receptor Activity: GIP and GLP-1 receptor agonist
Research Use Only: Not intended for human or veterinary use.